Jane Street’s Blueprint Medicines BPMC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-580,600
| Closed | -$74.4M | – | 10811 |
|
|
2025
Q2 | $74.4M | Sell |
580,600
-146,600
| -20% | -$15.2M | 0.01% | 576 |
|
|
2025
Q1 | $64.4M | Sell |
727,200
-49,600
| -6% | -$4.84M | 0.02% | 533 |
|
|
2024
Q4 | $67.8M | Sell |
776,800
-604,700
| -44% | -$55.4M | 0.01% | 567 |
|
|
2024
Q3 | $128M | Sell |
1,381,500
-78,800
| -5% | -$7.83M | 0.03% | 321 |
|
|
2024
Q2 | $157M | Buy |
1,460,300
+847,400
| +138% | +$84.8M | 0.04% | 260 |
|
|
2024
Q1 | $58.1M | Buy |
612,900
+81,800
| +15% | +$7.02M | 0.01% | 562 |
|
|
2023
Q4 | $49M | Buy |
531,100
+463,500
| +686% | +$30M | 0.01% | 689 |
|
|
2023
Q3 | $3.39M | Buy |
67,600
+7,400
| +12% | +$395K | ﹤0.01% | 3181 |
|
|
2023
Q2 | $3.8M | Sell |
60,200
-86,700
| -59% | -$4.71M | ﹤0.01% | 3133 |
|
|
2023
Q1 | $6.61M | Buy |
146,900
+48,200
| +49% | +$2.17M | ﹤0.01% | 2089 |
|
|
2022
Q4 | $4.32M | Sell |
98,700
-7,600
| -7% | -$364K | ﹤0.01% | 2677 |
|
|
2022
Q3 | $7M | Buy |
106,300
+61,200
| +136% | +$3.93M | ﹤0.01% | 2126 |
|
|
2022
Q2 | $2.28M | Buy |
45,100
+22,700
| +101% | +$1.33M | ﹤0.01% | 3914 |
|
|
2022
Q1 | $1.43M | Buy |
22,400
+18,100
| +421% | +$1.3M | ﹤0.01% | 5389 |
|
|
2021
Q4 | $461K | Buy |
4,300
+1,500
| +54% | +$157K | ﹤0.01% | 7425 |
|
|
2021
Q3 | $288K | Sell |
2,800
-24,900
| -90% | -$2.32M | ﹤0.01% | 8266 |
|
|
2021
Q2 | $2.44M | Buy |
27,700
+3,900
| +16% | +$357K | ﹤0.01% | 3946 |
|
|
2021
Q1 | $2.31M | Sell |
23,800
-1,200
| -5% | -$120K | ﹤0.01% | 3742 |
|
|
2020
Q4 | $2.8M | Buy |
25,000
+7,200
| +40% | +$759K | ﹤0.01% | 2909 |
|
|
2020
Q3 | $1.65M | Sell |
17,800
-28,900
| -62% | -$2.23M | ﹤0.01% | 3327 |
|
|
2020
Q2 | $3.64M | Buy |
46,700
+22,900
| +96% | +$1.55M | ﹤0.01% | 2240 |
|
|
2020
Q1 | $1.39M | Buy |
+23,800
| New | +$1.53M | ﹤0.01% | 2410 |
|
Other funds holding BPMC
IA
HNB
Jane Street's BPMC Position: Q3 2025 in Review
Jane Street sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 214,394 shares — an estimated $27.5M sold.
Jane Street first reported a position in BPMC in Q1 2017 and held it in 28 quarters. The position peaked at $35.6M in Q4 2024. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.
- Jane Street reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
- Jane Street sold 214,394 Blueprint Medicines shares in Q3 2025, an estimated $27.5M.
- Jane Street first reported a position in Blueprint Medicines in Q1 2017 and held it in 28 quarters.
- Jane Street's Blueprint Medicines position peaked at $35.6M in Q4 2024.
- 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.
Based on Jane Street's 13F filing for Q3 2025, filed 14 Nov 2025.